Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH plus TACE versus no LMWH in advanced hepatocellular carcinoma
ChiCTR-TRC-08000267Phase 4Completed
- Sponsor
- Third Affiliated Hospital of Naval Medical University
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of low molecular weight heparin calcium in hepatocellular carcinoma (HCC) (2 arms), sponsored by Third Affiliated Hospital of Naval Medical University. Primary endpoints: survival time and survival time with no progress of tumour. Started Dec 2008; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-08000267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000267.